{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:39Z","timestamp":1777866279489,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science &amp; Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/ PR41408 \/MED\/29\/1547\/2020"],"award-info":[{"award-number":["BT\/ PR41408 \/MED\/29\/1547\/2020"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science &amp; Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["MoE-STARS-2\/2023\\u20130249"],"award-info":[{"award-number":["MoE-STARS-2\/2023\\u20130249"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011581","name":"Indian Institute of Technology Indore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007116","name":"Indian Institute of Science Education and Research Pune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126952","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T04:51:38Z","timestamp":1740977498000},"page":"126952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum"],"prefix":"10.1016","volume":"53","author":[{"given":"Bhagyashree","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay Kumar","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya","family":"Athale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishanpal","family":"Karmodiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126952_bb0005","series-title":"World malaria report 2022","author":"W. H. Organization","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126952_bb0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S1473-3099(22)00273-0","article-title":"Efficacy of RTS, S\/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5\u201317 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial","volume":"22","author":"Samuels","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0015","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.126952_bb0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QCO.0000000000000766","article-title":"Artemisinin and multidrug-resistant plasmodium falciparum - a threat for malaria control and elimination","volume":"34","author":"Dhorda","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0169-4758(96)10055-7","article-title":"Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria","volume":"12","author":"White","year":"1996","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2025.126952_bb0035","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of artemisinin-resistant plasmodium falciparum malaria in eastern India","volume":"379","author":"Das","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.126952_bb0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ng.2624","article-title":"Multiple populations of artemisinin-resistant plasmodium falciparum in Cambodia","volume":"45","author":"Miotto","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2025.126952_bb0045","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/657120","article-title":"Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia","volume":"51","author":"Noedl","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among plasmodium falciparum in Southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria vaccines since 2000: progress, priorities, products","volume":"5","author":"Duffy","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.126952_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-micro-090817-062427","article-title":"The promise of a malaria vaccine\u2014are we closer?","volume":"72","author":"Laurens","year":"2018","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/156652406776055221","article-title":"Clinical immunity to malaria","volume":"6","author":"Schofield","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2025.126952_bb0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.126952_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0035-9203(63)90058-0","article-title":"Treatment of east African P. falciparum malaria with west African human \u03b3-globulin","volume":"57","author":"McGregor","year":"1963","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.126952_bb0080","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(62)90725-0","article-title":"Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians","volume":"280","author":"Edozien","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.126952_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2012.11.002","article-title":"New approaches to studying plasmodium falciparum merozoite invasion and insights into invasion biology","volume":"43","author":"Boyle","year":"2013","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0014-5793(00)01703-8","article-title":"Functional analysis of proteins involved in plasmodium falciparum merozoite invasion of red blood cells","volume":"476","author":"Cowman","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2025.126952_bb0095","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1126\/science.803712","article-title":"Invasion of erythrocytes by malaria merozoites","volume":"187","author":"Dvorak","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.126952_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-8674(95)90054-3","article-title":"Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes","volume":"82","author":"Baruch","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.126952_bb0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.micro.61.080706.093134","article-title":"Antigenic variation in Plasmodium falciparum","volume":"62","author":"Scherf","year":"2008","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0110","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1681\/ASN.V11112147","article-title":"Malarial acute renal failure","volume":"11","author":"Barsoum","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068368","article-title":"Expression of the domain cassette 8 plasmodium falciparum erythrocyte membrane protein 1 is associated with cerebral malaria in Benin","volume":"8","author":"Bertin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126952_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.813011","article-title":"Plasmodium falciparum parasite lines expressing DC8 and group a PfEMP1 bind to brain, intestinal, and kidney endothelial cells","volume":"12","author":"Ortolan","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0125","article-title":"Tissue tropism in parasitic diseases","volume":"9","author":"Silva Pereira","year":"2019","journal-title":"Open Biol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0130","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.vaccine.2004.02.015","article-title":"Immunization with PfEMP1-DBL1\u03b1 generates antibodies that disrupt rosettes and protect against the sequestration of plasmodium falciparum-infected erythrocytes","volume":"22","author":"Chen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126952_bb0135","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.apjtb.2017.09.017","article-title":"Acquisition of naturally acquired antibody response to plasmodium falciparum erythrocyte membrane protein 1-DBL\u03b1 and differential regulation of IgG subclasses in severe and uncomplicated malaria","volume":"7","author":"Horata","year":"2017","journal-title":"Asian Pac J Trop Biomed"},{"key":"10.1016\/j.vaccine.2025.126952_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137262","article-title":"Longitudinal analysis of naturally acquired PfEMP1 CIDR domain variant antibodies identifies associations with malaria protection","volume":"5","author":"Obeng-Adjei","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2025.126952_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00622-17","article-title":"Natural and vaccine-induced Acquisition of Cross-Reactive IgG-inhibiting ICAM-1-specific binding of a plasmodium falciparum PfEMP1 subtype associated specifically with cerebral malaria","volume":"86","author":"Olsen","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126952_bb0150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2019.10.012","article-title":"Protective immunity against Severe malaria in children is associated with a limited repertoire of antibodies to conserved PfEMP1 variants","volume":"26","author":"Tessema","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2025.126952_bb0155","doi-asserted-by":"crossref","first-page":"247ra102","DOI":"10.1126\/scitranslmed.3008705","article-title":"New antigens for a multicomponent blood-stage malaria vaccine","volume":"6","author":"Osier","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.126952_bb0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12936-021-04020-6","article-title":"Naturally acquired antibody response to a plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48\/45) in individuals living in Brazilian malaria-endemic areas","volume":"21","author":"Baptista","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2025.126952_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163066","article-title":"Safety and immunogenicity of EBA-175 RII-NG malaria vaccine administered intramuscularly in semi-immune adults: a phase 1, double-blinded placebo controlled dosage escalation study","volume":"11","author":"Koram","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126952_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0141-9838.2004.00705.x","article-title":"Natural antibody response to plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection","volume":"26","author":"Meraldi","year":"2004","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.medj.2021.03.014","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","author":"Minassian","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.vaccine.2025.126952_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","article-title":"Vaccination with a CD4(+) and CD8(+) T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis","volume":"200","author":"Dias","year":"2018","journal-title":"Transl Res"},{"key":"10.1016\/j.vaccine.2025.126952_bb0185","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3389\/fmicb.2017.02692","article-title":"Designing a B cell-based vaccine against a highly variable hepatitis C virus","volume":"8","author":"Fuerst","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against toxoplasma gondii infection: a mini-review","volume":"6","author":"Hajissa","year":"2019","journal-title":"J Adv Vet Res"},{"key":"10.1016\/j.vaccine.2025.126952_bb0195","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1080\/14760584.2021.1974298","article-title":"Immunoinformatics driven construction of multi-epitope vaccine candidate against Ascaris lumbricoides using its entire immunogenic epitopes","volume":"20","author":"Kaur","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.126952_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/vaccines12040351","article-title":"Design and evaluation of chimeric plasmodium falciparum Circumsporozoite protein-based malaria vaccines","volume":"12","author":"Stump","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.126952_bb0205","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/IAI.00522-13","article-title":"A chimeric plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies","volume":"81","author":"Alaro","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126952_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12936-016-1226-5","article-title":"Immunogenicity of a chimeric plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys","volume":"15","author":"Burns","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2025.126952_bb0215","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.2000927","article-title":"Inclusion of an optimized plasmodium falciparum merozoite surface protein 2\u2013based antigen in a trivalent, multistage malaria vaccine","volume":"206","author":"Eacret","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232355","article-title":"Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination","volume":"15","author":"Parzych","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126952_bb0225","doi-asserted-by":"crossref","unstructured":"Y. Fastman, R. Noble, M. Recker, R. Dzikowski, Erasing the epigenetic memory and beginning to switch--the onset of antigenic switching of var genes in Plasmodium falciparum. PLoS One 7, e34168 (2012).","DOI":"10.1371\/journal.pone.0034168"},{"key":"10.1016\/j.vaccine.2025.126952_bb0230","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1128\/EC.00173-07","article-title":"Antigenic variation in plasmodium falciparum: gene organization and regulation of the var multigene family","volume":"6","author":"Kyes","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.vaccine.2025.126952_bb0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.126952_bb0240","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkn254","article-title":"Immune epitope database analysis resource (IEDB-AR)","volume":"36","author":"Zhang","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2025.126952_bb0245","doi-asserted-by":"crossref","first-page":"47533","DOI":"10.1074\/jbc.M207145200","article-title":"Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth","volume":"277","author":"Aoki","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2025.126952_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0166-6851(98)00010-3","article-title":"Predicted and observed alleles of plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen","volume":"92","author":"Qari","year":"1998","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032242","article-title":"High affinity antibodies to plasmodium falciparum merozoite antigens are associated with protection from malaria","volume":"7","author":"Reddy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126952_bb0260","series-title":"Ch\u2019ng, in malaria immunology: Targeting the surface of infected erythrocytes","first-page":"493","author":"M. d. P. Quintana, J.-H.","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126952_bb0265","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20040274","article-title":"Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group a var genes","volume":"199","author":"Jensen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.126952_bb0270","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.biocel.2008.12.012","article-title":"PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite plasmodium falciparum","volume":"41","author":"Pasternak","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/imr.12807","article-title":"Cerebral plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it","volume":"293","author":"Jensen","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2025.126952_bb0280","article-title":"Selection of plasmodium falciparum parasites for cytoadhesion to human brain endothelial cells","volume":"e3122","author":"Claessens","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2025.126952_bb0285","series-title":"In malaria immunology: Targeting the surface of infected erythrocytes","first-page":"515","author":"Azasi","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126952_bb0290","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pt.2020.12.008","article-title":"Bioengineered 3D microvessels for investigating plasmodium falciparum pathogenesis","volume":"37","author":"Bernabeu","year":"2021","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0295","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.bpj.2017.04.001","article-title":"Rolling adhesion of Schizont stage malaria-infected red blood cells in shear flow","volume":"112","author":"Dasanna","year":"2017","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2025.126952_bb0300","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.bpj.2011.03.027","article-title":"Wall shear stress-based model for adhesive dynamics of red blood cells in malaria","volume":"100","author":"Fedosov","year":"2011","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2025.126952_bb0305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bpj.2020.12.013","article-title":"Quantifying intracellular particle flows by DIC object tracking","volume":"120","author":"Chaphalkar","year":"2021","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2025.126952_bb0310","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/femsre\/fuw001","article-title":"Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria","volume":"40","author":"Beeson","year":"2016","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.126952_bb0315","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/IAI.00866-13","article-title":"Sequential processing of merozoite surface proteins during and after erythrocyte invasion by plasmodium falciparum","volume":"82","author":"Boyle","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126952_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002199","article-title":"An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.126952_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13030","article-title":"Neutralising antibodies block the function of Rh5\/Ripr\/CyRPA complex during invasion of plasmodium falciparum into human erythrocytes","volume":"21","author":"Healer","year":"2019","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0330","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1073\/pnas.0730883100","article-title":"Erythrocyte-binding antigen 175 mediates invasion in plasmodium falciparum utilizing sialic acid-dependent and -independent pathways","volume":"100","author":"Duraisingh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.126952_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/dde6c172-c9c3-43bb-8fc3-db54613d4424","article-title":"PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor","volume":"3","author":"Rodriguez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126952_bb0340","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciy1087","article-title":"Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2","volume":"69","author":"Dejon-Agobe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0345","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.01585-07","article-title":"Breadth and magnitude of antibody responses to multiple plasmodium falciparum merozoite antigens are associated with protection from clinical malaria","volume":"76","author":"Osier","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126952_bb0350","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiw039","article-title":"Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1\/AS01","volume":"213","author":"Payne","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0355","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S1473-3099(24)00312-8","article-title":"Blood-stage malaria vaccine candidate RH5.1\/matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-Centre, phase 1b trial","volume":"24","author":"Silk","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126952_bb0360","doi-asserted-by":"crossref","first-page":"1267372","DOI":"10.3389\/fimmu.2023.1267372","article-title":"Safety and immunogenicity of BK-SE36\/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial","volume":"14","author":"Ou\u00e9draogo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/768515","article-title":"Model for vaccine design by prediction of B-epitopes of IEDB given perturbations in peptide sequence, in vivo process, experimental techniques, and source or host organisms","volume":"2014","author":"Gonzalez-Diaz","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2025.126952_bb0370","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.4049\/jimmunol.0901331","article-title":"Sequential, ordered acquisition of antibodies to plasmodium falciparum erythrocyte membrane protein 1 domains","volume":"183","author":"Cham","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0375","article-title":"From in vivo to in vitro: dynamic analysis of plasmodium falciparum var gene expression patterns of patient isolates during adaptation to culture","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126952_bb0380","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pt.2016.07.003","article-title":"Functional antibodies and protection against blood-stage malaria","volume":"32","author":"Teo","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0385","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00155-17","article-title":"Merozoite surface protein 1 from plasmodium falciparum is a major target of opsonizing antibodies in individuals with acquired immunity against malaria","volume":"24","author":"Jaschke","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0390","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/icb.2009.27","article-title":"The future for blood-stage vaccines against malaria","volume":"87","author":"Richards","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2025.126952_bb0395","article-title":"World Health Organization, communicable diseases cluster","volume":"94","author":"Beales","year":"2000","journal-title":"Trans Royal Soc Tropic Med Hygiene"},{"key":"10.1016\/j.vaccine.2025.126952_bb0400","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jmi.12765","article-title":"Open source 3D-printed focussing mechanism for cellphone-based cellular microscopy","volume":"273","author":"Jawale","year":"2019","journal-title":"J Microsc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:21:52Z","timestamp":1777537312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":80,"alternative-id":["S0264410X2500249X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126952","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126952"}}